NCT00110422 Irbesartan in the Treatment of Hypertensive Patients With Metabolic Syndrome Status COMPLETED Phase PHASE4
NCT00106808 Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00104130 Study of KOS-862 (Epothilone D) in Metastatic Prostate Cancer Status TERMINATED Phase PHASE2
NCT00103844 Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia Status COMPLETED Phase PHASE2
NCT00103831 Oral Taxane in Combination With Pemetrexed (Alimta) in Patients With Recurrent Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00103701 BMS-354825 in Patients With Chronic Accelerated, or Blast Phase Chronic Myelogenous Leukemia or Philadelphia Positive Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE1
NCT00101816 Dasatinib (BMS-354825) in Subjects With Myeloid Blast Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib Mesylate Status COMPLETED Phase PHASE2
NCT00101660 Study of BMS-354825 (Dasatinib) in Patients With Chronic Myeloid Leukemia Who Are Either Resistant or Intolerant to Imatinib Status COMPLETED Phase PHASE2
NCT00101647 Study of Dasatinib (BMS-354825) in Patients With Accelerated Phase Chronic Myeloid Leukemia Status COMPLETED Phase PHASE2
NCT00101608 Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium Status COMPLETED Phase PHASE2
NCT00101595 Dasatinib (BMS-354825) in Subjects With Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE2
NCT00101192 Cetuximab and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer Status COMPLETED Phase PHASE2
NCT00099879 Study of BMS-275183 in Patients With Pre-treated Non-small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT00097357 BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery Status COMPLETED Phase PHASE2/PHASE3
NCT00097227 Trial of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE2
NCT00097214 Carboplatin Plus Cetuximab for Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE2
NCT00096811 Entecavir for Subjects With Chronic Hepatitis B Infection: An Early Access Program Status NO_LONGER_AVAILABLE Phase N/A
NCT00096785 Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection Status COMPLETED Phase PHASE3
NCT00096746 Effect of the Atazanavir (ATV) 150L Mutation on Subsequent Treatment Response in HIV Infected Subjects Status COMPLETED Phase N/A